Offering weight loss financing provides significant advantages for healthcare providers: Increases case acceptance for weight loss procedures Expands access to patients with high deductibles or partial insurance coverage Reduces financial objections during pricing discussions Improves revenue predictability through third-party lender payments Strengthens patient relationships by offering transparent, flexible options As demand for medical weight loss continues to grow, practices that provide accessible financing position themselves as patient-centered, responsive, and prepared to meet evolving financial realities
Retatrutides three arms, GLP-1, GIP, and glucagon, all engage at low doses
PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan and works consistently at your prescribed dose, regardless of whether you combine it with supplements
Continue for about 1 mile, then turn right onto N
GHRP-6 + GHRH combinations are extensively represented in earlier research literature